Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can screening for genetic markers improve peripheral artery bypass patency?

Journal of vascular surgery - 1 Dec 2002

Kibbe Melina R, Hassett Andrea L Cortese, McSherry Frances, Conner Philip, Bontempo Franklin A, Williford William, Johnson Willard, Makaroun Michel S

Abstract excerpt

OBJECTIVE: Three genetic mutations have been associated with an increased risk of thromboembolic events: factor V Leiden R506Q, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T (MTHFR) mutations. The aim of this study was to determine the effect of these mutations on patency of peripheral bypass procedures and preoperative and postoperative thromboembolic events. METHODS: Two hundred forty-four...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Follow-Up Studies
Share to Genetic Markers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Outcome Assessment, Health Care

Share to Peripheral Vascular Diseases

Share to Postoperative Complications

Share to Predictive Value of Tests

Share to Random Allocation

Share to Thromboembolism

Source

Identifiers

PMID: 12469051
DOI: 10.1067/mva.2002.128937

Genes

MTHFR
APP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can screening for genetic markers improve peripheral artery bypass patency?PMID 12469051Read ↗

The role of genetics in coronary artery bypass surgery patients under 30 years of age.Semantic proximity Read ↗

Thrombotic gene polymorphisms and postoperative outcome after coronary artery bypass graft surgery.Semantic proximity Read ↗

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.Semantic proximity Read ↗

Platelet gene polymorphisms and cardiac risk assessment in vascular surgical patients.Semantic proximity Read ↗

Assessment of Genetic Variants Linked to Susceptibility to Mechanical Prosthetic Valve Thrombosis.Semantic proximity Read ↗

Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes.Semantic proximity Read ↗

Genetic variants associated with vein graft stenosis after coronary artery bypass grafting.Semantic proximity Read ↗

Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.Semantic proximity Read ↗

Single nucleotide polymorphism (G994-->T) in the plasma platelet-activating factor-acetylhydrolase gene is associated with graft patency of femoropopliteal bypass.Semantic proximity Read ↗

The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients.Semantic proximity Read ↗

Thrombophilic risk factors for symptomatic peripheral arterial disease.Semantic proximity Read ↗

Role of genetic mutations in vascular access thrombosis among hemodialysis patients waiting for renal transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.